Keyphrases
Adverse Cardiac Remodeling
12%
Analysis of Covariance
6%
Atrial Fibrillation
6%
Body Exercise
6%
Body Mass Index
6%
Cardiac Function
100%
Cardiac Structure
100%
Clinical Characteristics
6%
Diabetes
6%
Disease-modifying Therapy
6%
E Wave
12%
Early Diastolic Mitral Annular Velocity
6%
Early-late
6%
Echocardiographic Characteristics
6%
Echocardiography
25%
End-diastolic Area
12%
Exercise Function
6%
Heart Failure
100%
Heart Failure with Preserved Ejection Fraction (HFpEF)
50%
Inflow Velocity
12%
Left Atrial Remodeling
6%
Left Atrial Volume
18%
Left Ventricular Dimensions
6%
Mass Function
6%
Mitral Inflow
12%
Obesity
6%
Once-weekly Semaglutide
12%
Parameter Values
6%
Patients with Obesity
100%
People with Obesity
37%
Physical Limitations
6%
Placebo
31%
Right Ventricular
18%
Right Ventricular Enlargement
6%
Semaglutide
100%
Semaglutide 2.4 Mg
12%
Systolic Area
6%
Systolic Function
6%
Treatment Effect
50%
Type 2 Diabetes Mellitus (T2DM)
6%
Velocity Ratio
6%
Wave Velocity
12%
Weight Function
6%
Weight Loss
6%
Medicine and Dentistry
Analysis of Covariance
5%
Atrial Fibrillation
5%
Body Mass Index
5%
Body Weight
5%
Congestive Heart Failure
100%
Diabetes
5%
Diseases
5%
Echocardiography
22%
Heart Atrium Remodeling
5%
Heart Failure with Preserved Ejection Fraction
22%
Heart Ventricle Remodeling
11%
Maturity Onset Diabetes of the Young
5%
Patient with Obesity
100%
Placebo
27%
Semaglutide
100%
Systolic Function
5%
Treatment Effect
44%